Stock Rich List
#3762 on the rich list of 14,644 insiders

Vision Scs F2

10% owner at Cullinan Therapeutics.

$30.2M
in disclosed stock, +$200K (+0.67%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
Rank
3762nd of 14,644
Companies held
1
Largest holding
CGEM, 100.0% of total
Latest SEC filing
May 16, 2022

What the $30.2M is made of

Holdings counted

All filings on SEC.gov
CompanyHow heldSharesPriceValueShare of totalReported
Cullinan Therapeutics CGEM
Common Stock
Directly1,305,873$9.07$11.8M39.2%Form 4, May 16, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 Bioscience I 2017 Ltd.639,295$9.07$5.8M19.2%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through Globeways Holdings Ltd.
Reported jointly by 2 insiders; split evenly
568,263$9.07$5.2M17.1%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2-TPO Investments, LLC
Reported jointly by 2 insiders; split evenly
311,088$9.07$2.8M9.3%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 MG Ltd.
Reported jointly by 2 insiders; split evenly
162,667$9.07$1.5M4.9%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through Morana Jovan-Embiricos112,507$9.07$1.0M3.4%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 MC, LLC
Reported jointly by 2 insiders; split evenly
107,399$9.07$974K3.2%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 Bio TD, LLC71,599$9.07$649K2.1%Form 4, May 12, 2022
Cullinan Therapeutics CGEM
Common Stock
Through F2 GC, LLC
Reported jointly by 2 insiders; split evenly
52,381$9.07$475K1.6%Form 4, May 12, 2022

Share counts are the amounts Vision Scs F2 reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.

Nearby on the list

Full list
Nearby ranks
RankNameStock holdingsToday
3759Shelley Simpson
President and CEO, J.B. Hunt Transport Services. Lowell, AR
$30.2M−$274K (−0.90%)
3760Michael Koehnen
Director, TriCo Bancshares. Chico, CA
$30.2M−$435K (−1.42%)
3761Larry Wood
Global President TAVR & Surg, Edwards Lifesciences. San Jose, CA
$30.2M−$87K (−0.29%)
3762Vision Scs F2
10% owner, Cullinan Therapeutics
$30.2M+$200K (+0.67%)
3763David Slater
Exec. Chair and CEO, DT Midstream. Detroit, MI
$30.2M−$886K (−2.85%)
3764Johnny Trotter
Director, First Financial Bankshares. Abilene, TX
$30.2M−$338K (−1.11%)
3765Seth Demsey
Co-Chief Executive Officer, Corvex. Arlington, VA
$30.2M−$3.8M (−11.14%)

Other Cullinan Therapeutics insiders

All CGEM insiders

Questions

How much stock does Vision Scs F2 own?

Vision Scs F2 holds $30,212,809 in listed stock based on SEC filings and current prices, mostly Cullinan Therapeutics (CGEM). That ranks 3762nd on the Stock Rich List.

Is this Vision Scs F2's net worth?

No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.

Files jointly with Morana Jovan-Embiricos.